Discontinued — last reported Q4 '14
An increase in impairment charges signals that the company's previous growth or profitability expectations for acquired assets were overly optimistic, potentially indicating operational challenges or market deterioration within the segment. A decrease or absence of impairment suggests that the assets are performing in line with or exceeding the valuation models used during their acquisition.
This metric represents the non-cash charge recognized when the carrying amount of finite-lived intangible assets, such a...
Peers in the life sciences and diagnostics sectors frequently report these charges following M&A activity, with investors comparing the frequency and magnitude of these write-downs to assess the company's historical capital allocation and acquisition discipline.
a_segment_assetimpairment_impairment_of_intangible_assets_finitelived